谷歌浏览器插件
订阅小程序
在清言上使用

Tu1867 EFFICACY OF TOFACITINIB DOSE ESCALATION TO 10 MG BID IN PATIENTS WITH ULCERATIVE COLITIS AFTER COMPLETING MAINTENANCE THERAPY IN REMISSION AND LOSING RESPONSE: DATA FROM OCTAVE OPEN-LABEL, LONG-TERM EXTENSION STUDY

Gastroenterology(2020)

引用 0|浏览34
暂无评分
关键词
ulcerative colitis,tofacitinib dose escalation,tu1867 efficacy,completing maintenance therapy,remission,open-label,long-term
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要